Nuvo Pharmaceuticals Inc (MRVFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 54,981 | 55,073 | 52,410 | 15,429 | 13,517 |
| Cost of Goods | 19,466 | 17,400 | 19,949 | 6,664 | 6,260 |
| Gross Profit | 35,515 | 37,673 | 32,461 | 8,764 | 7,257 |
| Operating Expenses | 25,437 | 22,896 | 28,073 | 14,726 | 6,193 |
| Operating Income | 10,544 | 15,177 | 5,337 | -5,298 | 1,325 |
| Interest Expense | 8,061 | 8,541 | 7,766 | 0 | 0 |
| Other Income | -25,899 | -8,859 | 4,983 | 407 | -104 |
| Pre-tax Income | -23,416 | -2,222 | 2,554 | -4,891 | 1,220 |
| Income Tax | 2,280 | 860 | 21 | -144 | 1 |
| Net Income Continuous | -25,696 | -3,082 | 2,533 | -4,747 | 1,220 |
| Net Income | $-25,696 | $-3,082 | $2,533 | $-4,747 | $1,220 |
| EPS Basic Total Ops | -2.26 | -0.27 | 0.23 | -0.42 | 0.11 |
| EPS Basic Continuous Ops | -2.26 | -0.27 | 0.22 | -0.41 | 0.11 |
| EPS Diluted Total Ops | -2.26 | -0.27 | -0.38 | -0.42 | 0.09 |
| EPS Diluted Continuous Ops | -2.26 | -0.27 | 0.06 | -0.41 | 0.10 |
| EPS Diluted Before Non-Recurring Items | -0.48 | -0.01 | -0.38 | -0.29 | 0.09 |
| EBITDA(a) | $16,967 | $22,087 | $12,531 | $-3,375 | $1,524 |